Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,567
+$40 QoQ
Shares Held
10
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,594
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Private Wealth Management Group, LLC holds $3,659,627 across 12 Drug Manufacturers - General names. NVS ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,022 | $2,545,287 | |
| 2 | MRK |
Merck & Co., Inc.
|
2,491 | $320,093 | |
| 3 | LLY |
ELI LILLY & Co
|
248 | $297,458 | |
| 4 | ABBV |
AbbVie Inc.
|
1,170 | $294,418 | |
| 5 | PFE |
Pfizer Inc
|
3,822 | $92,033 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
251 | $31,711 | |
| 7 | AMGN |
Amgen Inc
|
82 | $29,693 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
457 | $26,332 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,567 | 10 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,527 | 10 | Shares | Sole | 2026-04-23 | |
| No filing history on record for this holder in this stock. | ||||||